Akrivia Health

News

Volunteers with schizophrenia, bipolar, and depression will take part in an NHS study that will use genetic and health data to find new therapies.

News

Biogen will advance its tau-targeting Alzheimer's disease drug diranersen into phase 3, even though it missed the main endpoint in a midstage trial.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.